The studies were designed to determine whether torcetrapib/Lipitor therapy can effectively raise HDL (‘good’) cholesterol while lowering LDL (‘bad’) cholesterol, a leading risk factor for heart disease. In
European orphan drug designation is designed to encourage companies to develop and market treatments for rare, life-threatening medical conditions that affect fewer than five people in every 10,000
Under the terms of the license agreement, American BioScience will receive upfront and milestone payments in excess of $50 million, in addition to substantial royalties. Abraxane for injectable
The companies originally entered into an agreement in December 2004, under which Johnson & Johnson was to pay $25.4 billion for Guidant. However, product recalls at Guidant and
The company’s phase II follow-on study of Flurizan in patients with mild Alzheimer’s disease showed that study participants improved as a group, regaining cognitive ability from months 12
Medarex expects to receive an undisclosed milestone payment from its licensee, Bristol-Myers for the advancement into clinical trials of BMS-66513, a fully human antibody that targets CD137, for
The dose-escalating, safety and tolerability study of the drug will be conducted at multiple sites in Australia and undertaken under both US and Australian regulatory authorizations. Xenome has
The grant will support preclinical studies to determine the optimal Oxiplex gel for injectable delivery of a bone growth peptide, and to evaluate the efficacy of the peptide
Azithromycin is the AB-rated generic equivalent of Pfizer’s Zithromax, an antibiotic indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of bacteria.
The preventive HIV vaccine candidate, tgAAC09, utilizes a recombinant adeno-associated viral vector (rAAV) that was developed with and manufactured by Targeted Genetics Corporation. Under the terms of a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.